Norrby S, Nord CE, Finch R: Lack of development of new antimicrob

Norrby S, Nord CE, Finch R: Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005, 5:115–9.PubMed 3. Lehrer RI, Ganz T: Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 2002, 9:18–22.PubMedCrossRef 4. Lehrer RI: Primate defensins. Nature Rev Microbiol 2004, 2:727–738.CrossRef 5. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004, buy Tariquidar 22:181–215.PubMedCrossRef 6. Mygind PH, Fischer RL, et al.: Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005, 437:975–80.PubMedCrossRef

7. Gottlieb CT, Thomsen LE, Ingmer H, Mygind PH, Kristensen H-H, Gram L: Antimicrobial peptides effectively kill a broad spectrum of Listeria monoc ytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol

2008, 8:205.PubMedCrossRef 8. Waldvogel FA: Staphylococcus aureus . In Principles and practice of infectious diseases. Edited by: Mandell GL, Bennet JE, Dolio R. New York: Churchill Livingstone; 1995:1754–1777. 9. Vazquez-Boland SC79 JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, Gonzalez-Zorn B, Wehland J, Kreft J: Listeria Pathogenesis and Molecular Virulence Determinants. Clin Microbiol Rev 2001, 14:584–640.PubMedCrossRef 10. Brogden KA: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria. Nat Rev Microbiol 2005, 3:238–250.PubMedCrossRef Fossariinae 11. Ando T, Watanabe S: A new method for fractionation of protamines and amino acid sequences of salmine and 3 components of iridine. Int J Protein Res 1969, 1:221–224.PubMedCrossRef 12. Schneider T, Kruse T, Wimmer R, et al.: Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328:1168–1172.PubMedCrossRef 13. Hale JD, Hancook RE: Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert

rec Anti Inf Ther 2007, 5:951.CrossRef 14. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J, Anderson KL, Dunman PM, Joyce S, Skaar EP: A Staphylococcus aureus regulatory system that Temsirolimus responds to host heme and modulates virulence. Cell Host microbe 2007, 1:109–119.PubMedCrossRef 15. Everse J, Hsia N: The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997, 22:1075–1099.PubMedCrossRef 16. Stauff DL, Torres VJ, Skaar EP: Signaling and DNA-binding activities of the Staphylococcus aureus HssR-HssS two-component system required for heme sensing. J Biol Chem 2007, 282:26111–26121.PubMedCrossRef 17. Stauff DL, Bagaley D, Torres VJ, Joyce R, Anderson KL, Kuechenmeister L, Dunman PM, Skaar EP: S taphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J Bacteriol 2008, 190:3588–3596.

Comments are closed.